Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Just How Much Can Remote Patient Monitoring Technology Scale? —featuring Dan Vah

Since the pandemic many health care providers have shifted to a remote approach. Though, not every provider looks to improve the root of total health. How can we power proactive, predictive health from real-time patient data with prevention in mind - all remotely? Dan Vahdat is the CEO and Founder of Medopad, a global HealthTech AI company with a vision to create a world where people can live longer. His professional career spans from IT to medical technology including several years at Johns Hopkins University. On this episode of HLTH Matters, Dan joins hosts Dr. Gautam Gulati and Dr. Jordan Shlain to discuss the future of remote patient monitoring not only in the U.S. but in countries around the entire world. He describes exactly how the remote monitoring process works for clients at Huma, the constraints found in America compared to other countries, as well as how technology can help at a scale compared to physical care alone. Listen in to how Huma is working with countries all over the world to provide remote care that brings each patient proactive data that allows Huma to power predictive health and prevention. Topics Covered <ul><li>What Huma does and how the company came about</li><li>How the remote monitoring process works at Huma</li><li>What the exact care process looks like for clients</li><li>How technology innovations have benefited the health care system</li><li>How Dan and his team are handling the flow of communications at Huma</li><li>Dan’s insight on the differences being seen in remote patient monitoring in the US versus in European countries</li><li>The biggest constraints found in America with remote healthcare</li><li>Dan’s insight on the non-traditional players who act as competition</li><li>What the future of Huma and Remote Patient Monitoring looks like</li><li>The possible limits with remote telehealth</li><li>How Dan defines health</li><li>How Dan defines health care as care with a smile</li></ul> Connect with Dan Vahdat<a href="https://huma.com/" target="_blank">Huma</a> Connect with Dr. Gautam Gulati &amp; Dr. Jordan Shlain<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a><a href="https://www.linkedin.com/in/drjordanshlain/" target="_blank">Dr. Shlain on LinkedIn</a><a href="https://twitter.com/DrShlain" target="_blank">Dr. Shlain on Twitter</a>  Introductory Quote[4:00–4:49]“In the past 18 months we have done national projects. Not one hospital, not two hospitals, not one region - across large scale countries as big as Germany, UK, France and not only modern countries but countries like India…and so on. Projects that are quite big..We have shipped millions of devices for our projects…This showed that technology can help at scale.

S2 Ep17: Just How Much Can Remote Patient Monitoring Technology Scale? —featuring Dan Vahdat

CEO & Founder

Techquity and Community Work—featuring Theresa Demeter

Let’s talk about health equity and quality of care since they are two sides of the same coin. In this episode, Theresa Demeter, Managing Director at Tegria, talks about how healthcare should approach technology solutions that address equity by working directly with some communities. As great as it is for health equity and “techquity” to be the buzzwords at the HLTH conference, Theresa believes it’s essential to acknowledge that technology can leave certain groups behind if companies don’t think of them when devising solutions. She shares Tegria’s experience of bringing technology and education to a remote southeast Alaskan community that might need action plans to access care in case of emergencies. Theresa also explains how they approach these communities through health advocates and partnerships with other industries. Tune in to learn more about Tegria’s techquity work! About Theresa Demeter:Theresa Demeter is an entrepreneurial executive administrator with 30 years of healthcare performance and operational experience. In her role as a Managing Director at Tegria, she brings her passion for conceptualizing and implementing innovative solutions that drive quality and performance improvement to optimize patient outcomes. Theresa developed Tegria’s offering that helps healthcare organizations prioritize and operationalize their health equity strategy and mitigate the harmful effects of implicit bias through macro-simulation. Prior to joining Tegria, Theresa drove the formation and expansion of InSytu, a national leader in clinical process improvement consulting powered by macro-simulation. She also served as the Director of Women and Infants Outpatient Services at Swedish Health Services in Seattle. Theresa earned a master’s degree in healthcare administration from the University of Washington and is a certified childbirth and parenting educator and doula. Things You’ll Learn:<ul><li>Technology can depend significantly on having access to a high-quality broadband service, something that some people still don’t have daily.</li><li>Healthcare companies should always devise their health tech solutions thinking of access issues for people in rural settings and income issues for people in urban environments.</li><li>Techquity is the intentional and thoughtful development of healthcare-related technology without excluding anybody.</li><li>On some occasions, people have better health outcomes when they can stay within their community rather than moving away from them.</li><li>Health advocates are people who build trust by bridging health companies with communities.</li><li>Healthcare has to make partnerships to address issues that affect a patient’s health, like their social determinants.</li></ul> Resources:<ul><li>Connect and follow Theresa Demeter on <a href="https://www.linkedin.com/in/theresa-demeter-mha-01724212/" target="_blank">LinkedIn</a></li><li>Follow Tegria on <a href="https://www.linkedin.com/company/tegria/" target="_blank">LinkedIn</a> </li><li>Discover the Tegria <a href="https://www.tegria.com/" target="_blank">Website</a></li><li>Listen to Theresa’s previous interview from ViVE <a href="https://www.viveevent.com/podcast/solutions-s1-ep7-the-road-to-equitable-healthcare-featuring-theresa-demeter-of-tegria" target="_blank">here</a>!</li><li>Visit the HLTH Foundation <a href="https://hlthfoundation.org/" target="_blank">Website</a>!</li><li>Check out Tegria’s pictures of their trip to Alaska <a href="https://www.tegria.com/tegria-news/bridging-barriers-closing-gaps-searhc-simulations-build-community-resilience/" target="_blank">here</a>!</li></ul>

S3 Ep22: Techquity and Community Work—featuring Theresa Demeter

The Future of Healthcare for the Labor Workforce—featuring Matthew Condon

Technology innovation can revolutionize the compensation and healthcare experience of workers. Matthew Condon, founder and Chief Executive Officer of Bardavon Health Innovations, believes employee healthcare delivery needs to be reformed and shares his thoughts in this episode. Historically, workers’ healthcare has been divided into benefits and compensation for work-related injuries. Still, a shift is happening amongst employers towards providing their associates with good healthcare, something that current digital, cloud-based prevention tools can enhance even more. Matthew explains how the tools Bardavon is betting on allow employers to understand the type of care their employees receive and help providers learn from each other to maximize the care experience. Matthew sees musculoskeletal treatments as an entry point to integrate new technology and create quantifiable results that incentivize change. Tune in to learn more about how Bardavon is revolutionizing healthcare for the labor workforce! About Matthew Condon:As the Founder &amp; Chief Executive Officer of Bardavon Health Innovations, LLC, Matthew J. Condon works tirelessly as a staunch advocate for transparency in healthcare and champions technology innovation within the industry that benefits injured Workers’ Compensation patients. He has been recognized nationally as an entrepreneur to watch by repeatedly forming game-changing companies that bring positive disruption to the marketplace. Bardavon is no different. With Bardavon, Matt has combined his passion for the industry and desire to make a difference with his storied experience of successfully running startups. The resulting effort is an industry-leading, healthcare data analytics company focused on promoting a culture of transparency in the Workers’ Compensation sector. Matt’s vision for Bardavon is to optimize the way patients, therapy providers, employers/carriers, and other key stakeholders interact with each other. By using clinical treatment data gathered through bNOTES®, its proprietary cloud-based clinical intelligence system, Bardavon is succeeding in its mission to change Workers’ Compensation. Combining clinical treatment data with claims data enables key stakeholders to define functional outcomes based on each individual patients’ health.  By deploying the Bardavon system, employers/carriers reduce consumption while concurrently improving the quality of physical/occupational therapy treatments. And when these processes are integrated using the Bardavon Digital Health Platform™, regional and national employers/carriers have saved millions. Bardavon is not Matt’s first foray into the world of healthcare, technology, and Worker’s Compensation. Matt founded ARC Physical Therapy+ (ARC) in 2003. It became one of the largest regional physical therapy clinics in the Midwest with 26 clinics in 2021, and over 100,000 annual patient visits. ARC was chosen as a Champion of Business by the Kansas City Business Journal for three straight years (2013, 2012 and 2011), earning a spot in the Hall of Champions. In 2013, ARC partnered with U.S. Physical Therapy Inc. and Matt started Bardavon. His focus was to build a platform where congruent companies could work together to focus on achieving optimized outcomes and returning injured Workers’ Compensation patients to full-duty. As we progress, Matt’s vision is to expand Bardavon’s footprint and move into the commercial musculoskeletal healthcare marketplace.  As a nationally recognized thought leader, Matt is a sought-after speaker and an author in the fields of healthcare, technology, and Workers’ Compensation. He was named a regional finalist for the Ernst &amp; Young “Entrepreneur of the Year” award, business magazine Ingram’s recognized Condon as a “Rainmaker,” and named him to its list of “40 under 40” high achievers, and since 2014, Condon has been included on the “Power 100” list published in the Kansas City Business Journal, which includes some of the most influential leaders in Kansas City’s business community. Things You’ll Learn:<ul><li>Bardavon Health is an industry-leading healthcare data analytics company focused on promoting a culture of transparency in the worker&#39;s compensation sector.</li><li>One way to address the current labor shortage is to make workers feel honored and fulfilled and give them good healthcare access whenever they have an injury.</li><li>Worker&#39;s compensation is under the property and casualty section of their company’s insurance plan.</li><li>As musculoskeletal issues continue to be a significant problem in the United States, more and more stakeholders will see it as an entry point for change and improvement.</li><li>Employers are responsible for taking their injured employees and ensuring they get to a quality care provider.</li></ul> Resources:<ul><li>Connect with and follow Matthew Condon on <a href="https://www.linkedin.com/in/matthew-condon-86905412/" target="_blank">LinkedIn</a>.</li><li>Follow Bardavon Health Innovations on <a href="https://www.linkedin.com/company/bardavon-health-innovations/" target="_blank">LinkedIn</a>.</li><li>Visit the Bardavon Health Innovations <a href="https://www.bardavon.com/" target="_blank">Website</a>!</li></ul>

S3 Ep37: The Future of Healthcare for the Labor Workforce—featuring Matthew Condon

Founder & Chief Executive Officer

Uncovering Early Cancer Detection

A mission to protect, maintain, and improve people&#39;s health BEFORE they get sick.  In this episode, Stephen Hahn, Chief Executive Officer at Harbinger Health, discusses the groundbreaking work being done at Harbinger, aiming at early disease detection and their commitment to making healthcare more accessible to all. Steve discusses the challenges and possibilities of early cancer detection using blood tests and the technological advancements being made to tackle these challenges. He explains how Harbinger&#39;s technology works and its potential impact on patients and physicians. Steve emphasizes the importance of addressing access issues in healthcare, particularly in relation to cancer screening and the economic benefits of early detection.  Dr. Hahn&#39;s compelling vision for a healthier future and his call to action to build trust make this episode an essential listen for everyone passionate about healthcare innovation and accessibility. About Stephen Hahn:Stephen M. Hahn, M.D., is CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger Health. Steve joined Flagship in June 2021 as Chief Medical Officer of its Preemptive Health and Medicine Initiative, which is creating a new field that aims to protect, maintain, or improve people’s health before they get sick. Steve will continue as a strategic advisor to the Initiative. Steve brings two decades of distinguished leadership in healthcare strategy, oncology medical practice, and translational/clinical research to this role. He served as the 24th U.S. Food and Drug Administration (FDA) Commissioner from 2019 to 2021 overseeing both COVID and non-COVID regulatory affairs, including therapeutics and vaccine development, devices, diagnostics, and clinical trials. Prior to his FDA appointment, Steve served as chief medical executive at the world-renowned MD Anderson Cancer Center in Houston. Prior to his role as chief medical executive, he served as deputy president and chief operating officer where he was responsible for the day-to-day operations of the nation’s top cancer center, which included leading more than 21,000 employees and overseeing a $5.2 billion operating budget. Steve was elevated to the chief operating officer role after serving as division head, department chair, and professor of Radiation Oncology. Prior to his executive leadership roles at MD Anderson, Dr. Hahn was the leader of radiation oncology at the University of Pennsylvania’s Perelman School of Medicine. Steve focused his translational research efforts on the evaluation of the tumor microenvironment, signal transduction pathways involved in tumor response to therapies and proton therapy. He has authored more than 220 peer-reviewed original research articles and has experience in medical product development. Steve earned his M.D. from Temple University and received his B.A. in Biology from Rice University. He was an internal medicine resident at the University of California San Francisco before completing a fellowship and residency at the National Cancer Institute in Bethesda, Maryland. Things You’ll Learn:<ul><li>Harbinger&#39;s mission is to find diseases early, before symptoms arise, to improve treatment outcomes and save lives. </li><li>Their focus on developing accessible and affordable diagnostics will revolutionize healthcare.</li><li>Dr. Hahn’s insights into Harbinger&#39;s innovative blood test, leveraging machine learning and AI to detect specific genetic signatures of cancer in the bloodstream. </li><li>This technology has the potential to revolutionize cancer screening and diagnosis.</li><li>The importance of building trust in healthcare. Access to affordable and reliable testing is vital, and Harbinger is committed to making its technologies accessible to all, regardless of location or socioeconomic status.</li></ul> Resources:<ul><li>Connect with and follow Stephen Hahn on <a href="https://www.linkedin.com/in/steve-hahn-4393348/" target="_blank">LinkedIn</a>.</li><li>Follow Harbinger Health on <a href="https://www.linkedin.com/company/harbinger-health/" target="_blank">LinkedIn</a> and visit their <a href="https://www.harbinger-health.com/" target="_blank">website</a>.</li></ul>

S4 E20: Uncovering Early Cancer Detection

Podcast

S2 Ep17: Just How Much Can Remote Patient Monitoring Technology Scale? —featuring Dan Vahdat

FEATURING